Effect of a mass treatment with praziquantel on the excretion in urine of a polysaccharide antigen used for diagnosis of schistosomiasis due to S. mansoni in Cameroon.
The detection in urine, with a monoclonal antibody, of an excreted polysaccharide antigen characteristic of the genus Schistosoma, allows evaluation of the effect of praziquantel used for mass treatment, in a focus of S. mansoni infection. Inhibition of the passive haemagglutination test, which was used for detecting the polysaccharide antigen in urine, is more sensitive for measuring prevalence than the determination of eggs in stools by means of direct examination and the formalin-ether concentration technique. Nine months after anthelminthic treatment, the percentage of inhabitants excreting antigen in urine diminished markedly, while the circulating antibody levels remained high. The test for detecting the antigen in urine seems to be the most efficient way to monitor the effect of mass treatment in intestinal schistosomiasis.